Medicine & Life Sciences
HIV
100%
HIV-1
51%
Tuberculosis
49%
HIV Infections
32%
rifapentine
25%
GSK1265744
22%
efavirenz
22%
Virus Diseases
20%
Rilpivirine
19%
Therapeutics
19%
Isoniazid
18%
CD4 Lymphocyte Count
17%
Ritonavir
17%
Pharmacokinetics
16%
Multidrug-Resistant Tuberculosis
15%
Acquired Immunodeficiency Syndrome
14%
Magnetoencephalography
13%
RNA
12%
Clinical Trials
12%
Reverse Transcriptase Inhibitors
12%
Brain
11%
Neurocognitive Disorders
11%
Pharmaceutical Preparations
10%
Rifampin
10%
Protease Inhibitors
10%
Atazanavir Sulfate
9%
Moxifloxacin
9%
Nucleosides
9%
Viral Load
9%
AIDS Dementia Complex
9%
Cognitive Dysfunction
9%
Injections
8%
Pulmonary Tuberculosis
8%
Infections
7%
GS-7340
7%
Dementia
7%
Darunavir
7%
Pre-Exposure Prophylaxis
6%
Nevirapine
6%
Tenofovir
6%
Lopinavir
6%
Pharmacists
6%
Safety
6%
Midwestern United States
6%
Patient Protection and Affordable Care Act
5%
Mycobacterium tuberculosis
5%
Viruses
5%
Cross-Sectional Studies
5%
Latent Tuberculosis
5%
Coinfection
5%
Population
5%
Opportunistic Infections
5%
Drug Resistance
5%
Confidence Intervals
5%